OpenAI acquires Orchestra Bio
· 1 min read · Summary from OpenAI
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Read the full story at OpenAI →